📰 Clinical Overview News
Clinical Overview News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Overview. Real-time updates on events, politics, business and more.
January 24, 2024
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The
January 3, 2024
ZILBRYSQ® is now commercially available by prescription in the United States and dispensed by UCBs selected exclusive specialty pharmacy PANTHERx® Rare Pharmacy.ZILBRYSQ is FDA-approved as the...
August 9, 2023
If a snake bites you, call 911 or your local emergency number right away, and then take these first-aid steps.
July 21, 2023
RYSTIGGO is now commercially available by prescription in the United States for adult patients with gMG who are anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody...
July 11, 2023
A recent study finds noninvasive brain stimulation techniques such as ECT, rTMS, and tDCS may be helpful for patients with catatonia.
June 30, 2023
UCB Presents Latest Data from Generalized Myasthenia Gravis Portfolio at 9th Congress of the European Academy of Neurology Meeting Results presented across...
June 27, 2023
UCB announces U.S. FDA approval of RYSTIGGO[®] (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis FDA approval of RYSTIGGO® (rozanolixizumab-noli) has been granted under...
January 6, 2023
Biologic License Application (BLA) designated Priority Review by FDA and seeks approval for rozanolixizumab for the treatment of adults with generalized...
January 6, 2023
UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review Biologic License... | January 6, 2023
November 23, 2022
Insulin delivery devices have evolved drastically since their invention in 1922. They are all aimed to provide insulin to the patients with minimal discomfort.